Načítá se...
Acceptance of the Deltoid Muscle Injection of Aripiprazole Long-acting Injectable in the Patients with Schizophrenia
OBJECTIVE: To improve poor medication adherence in schizophrenic patients, long-acting injectable (LAI) antipsychotics are used. However, it has not yet become common in Japan. Recently, aripiprazole LAI was approved for alternative injection into the deltoid muscle in addition to the gluteal muscle...
Uloženo v:
| Vydáno v: | Clin Psychopharmacol Neurosci |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Korean College of Neuropsychopharmacology
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7006984/ https://ncbi.nlm.nih.gov/pubmed/31958905 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9758/cpn.2020.18.1.49 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|